Herczeg, M., Demeter, F., Nagy, T., Rusznyák, Á., Hodek, J., Sipos, É., Lekli, I., Fenyvesi, F., Weber, J., Kéki, S., Borbás, A.: Block Synthesis and Step-Growth Polymerization of C-6-Sulfonatomethyl-Containing Sulfated Malto-Oligosaccharides and Their Biological Profiling.
Int. J. Mol. Sci. 25 (1), 1-29, 2024.

Feró, O., Szabóné, V., Nagy, É., Karányi, Z., Sipos, É., Engelhardt, J., Török, N., Balogh, I., Vető, B., Liko, I., Fóthi, Á., Szabó, Z., Halmos, G., Vécsei, L., Arányi, T., Székvölgyi, L.: DNA methylome, R-loop and clinical exome profiling of patients with sporadic amyotrophic lateral sclerosis.
Sci Data. 11 (1), 1-12, 2024.

Demeter, F., Peleskei, Z., Kútvölgyi, K., Rusznyák, Á., Fenyvesi, F., Kajtár, R., Sipos, É., Lekli, I., Molnár, P., Szöllősi, A., Lisztes, E., Tóth, I., Borbás, A., Herczeg, M.: Synthesis and Biological Profiling of Seven Heparin and Heparan Sulphate Analogue Trisaccharides.
Biomolecules. 14 (9), 1-24, 2024.

Fésüs, A., Baluku, P., Sipos, É., Somodi, S., Berczi-Kun, E., Lekli, I., Bácskay, I., Benkő, R., Vaskó, A.: The effect of the antibiotic stewardship program (ASP) on community-acquired pneumonia (CAP): a before-after study.
Front. Pharm. 15 1-12, 2024.

Fésüs, A., Ábrahám, A., Sipos, É., Szőke, K., Bak, I., Kiss-Szikszai, A., Lekli, I.: Evaluation of the antioxidant effect of kd15 and kd36 newly synthetized molecules.
In: FAMÉ 2023 Mátraháza 7-9 June 2023 : Programme Oral and Poster Abstract / org. Hungarian Society For Experimental And Clinical Pharmacology, Hungarian Physiological Society, Hungarian Society For Microcirculation And Vascular Biology, HUPHAR, [S.l.], 223, 2023.

Szabó, Z., Dezső, B., Molnár-Fodor, K., Szegedi, K., Flaskó, T., Szabó, E., Oláh, G., Sipos, É., Dobos, N., Gardi, J., Schally, A., Halmos, G.: Expression of Luteinizing Hormone-Releasing Hormone (LHRH) and Type-I LHRH Receptor in Transitional Cell Carcinoma Type of Human Bladder Cancer.
Molecules. 26 (5), 1-14, 2021.

Molnár-Fodor, K., Sipos, É., Dobos, N., Nagy, J., Steiber, Z., Méhes, G., Dull, K., Székvölgyi, L., Schally, A., Halmos, G.: Correlation between the Expression of Angiogenic Factors and Stem Cell Markers in Human Uveal Melanoma.
Life (Basel). 10 (12), 1-15, 2020.

Molnár-Fodor, K., Dobos, N., Schally, A., Steiber, Z., Oláh, G., Sipos, É., Székvölgyi, L., Halmos, G.: The targeted LHRH analog AEZS-108 alters expression of genes related to angiogenesis and development of metastasis in uveal melanoma.
Oncotarget. 11 (2), 175-187, 2020.

Halász, L., Karányi, Z., Boros-Oláh, B., Kuik-Rózsa, T., Sipos, É., Nagy, É., Mosolygó, Á., Türk-Mázló, A., Rajnavölgyi, É., Halmos, G., Székvölgyi, L.: Corrigendum: RNA-DNA hybrid (R-loop) immunoprecipitation mapping: an analytical workflow to evaluate inherent biases.
Genome Res. 29 (1), 157-157, 2019.

Sipos, É., Dobos, N., Rózsa, D., Molnár-Fodor, K., Oláh, G., Szabó, Z., Székvölgyi, L., Schally, A., Halmos, G.: Characterization of Luteinizing hormone-releasing hormone (LH-RH-I) receptor type I as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines.
OncoTargets Ther. 11 933-941, 2018.

Oláh, G., Dobos, N., Vámosi, G., Szabó, Z., Sipos, É., Molnár-Fodor, K., Harda, K., Schally, A., Halmos, G.: Experimental therapy of doxorubicin resistant human uveal melanoma with targeted cytotoxic luteinizing hormone-releasing hormone analog (AN-152).
Eur. J. Pharm. Sci. 123 371-376, 2018.

Sipos, É., Dull, K., Treszl, A., Steiber, Z., Méhes, G., Dobos, N., Molnár-Fodor, K., Oláh, G., Székvölgyi, L., Schally, A., Halmos, G.: Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.
Oncol. Rep. 37 1927-1934, 2017.

Halász, L., Karányi, Z., Boros-Oláh, B., Kuik-Rózsa, T., Sipos, É., Nagy, É., Mosolygó, Á., Türk-Mázló, A., Rajnavölgyi, É., Halmos, G., Székvölgyi, L.: RNA-DNA hybrid (R-loop) immunoprecipitation mapping: an analytical workflow to evaluate inherent biases.
Genome Res. 27 1063-1073, 2017.

Szabó, I., Bősze, S., Orbán, E., Sipos, É., Halmos, G., Kovács, M., Mező, G.: Comparative in vitro biological evaluation of daunorubicin containing GnRH-I and GnRH-II conjugates developed for tumor targeting.
J. Pept. Sci. 21 (5), 426-435, 2015.

Steiber, Z., Sipos, É., Dull, K., Halmos, G., Méhes, G., Treszl, A.: Aneuploidy of chromosome 3 and 4 in human uveal melanomas detected by fluorescence in situ hybridization.
Invest. Ophthalmol. Vis. Sci. 55 6444, 2014.

Hegedűs, R., Manea, M., Orbán, E., Szabó, I., Kiss, É., Sipos, É., Halmos, G., Mező, G.: Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin-GnRH-III bioconjugates.
Eur. J. Med. Chem. 56 155-165, 2012.